1. Raue F, Frank-Raue K. Multiple endocrine neoplasia type 2: 2007 update. Horm Res. 2007; 68(Suppl 5):101–4.
Article
2. Farndon JR, Leight GS, Dilley WG, Baylin SB, Smallridge RC, Harrison TS, et al. Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br J Surg. 1986; 73(4):278–81.
Article
3. Schimke RN. Multiple endocrine neoplasia: how many synd-romes? Am J Med Genet. 1990; 37(3):375–83.
Article
4. Norton JA, Froome LC, Farrell RE, Wells SA Jr. Multiple endocrine neoplasia type IIb: the most aggressive form of medullary thyroid carcinoma. Surg Clin North Am. 1979; 59(1):109–18.
Article
5. Raue F, Frank-Raue K, Grauer A. Multiple endocrine neoplasia type 2. Clinical features and screening. Endocrinol Metab Clin North Am. 1994; 23(1):137–56.
Article
6. Wells SA Jr, Dilley WG, Farndon JA, Leight GS, Baylin SB. Early diagnosis and treatment of medullary thyroid carcinoma. Arch Intern Med. 1985; 145(7):1248–52.
Article
7. Frank-Raue K, Rondot S, Raue F. Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC. Mol Cell Endocrinol. 2010; 322(1–2):2–7.
Article
8. Thakker RV, Ponder BA. Multiple endocrine neoplasia. Baillieres Clin Endocrinol Metab. 1988; 2(4):1031–67.
9. Easton DF, Ponder MA, Cummings T, Gagel RF, Hansen HH, Reichlin S, et al. The clinical and screening age-at-onset distribution for the MEN-2 syndrome. Am J Hum Genet. 1989; 44(2):208–15.
10. Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015; 25(6):567–610.
Article
11. Choi YS. Multiple endocrine neoplasia and familial medullary thyroid carcinoma. J Korean Thyroid Assoc. 2012; 5(2):124–31.
Article
12. Kim YL, Yoo SJ, Son HS, Yoon KH, Kang MI, Hong KS, et al. A case of multiple endocrine neoplasia, type 3. Korean J Intern Med. 1991; 41(5):703–9.
13. Cheon EM, Lee KH, Nam HS, Kwun GS, Kim HG, Yuh YJ, et al. A case of multiple endocrine neoplasia type IIb. Korean J Med. 1995; 49(3):400–6.
14. Lee CW, Oh CK, Jang HS, Kwon KS, Chung TA. A case of multiple endocrine neoplasia type 3 with multiple mucosal neuroma Korean J Dermatol. 1999; 37(4):505–9.
15. Kim TY, Hwang JK, Moon MK, Park YJ, Park DJ, Kim SY, et al. A case of multiple endocrine neoplasia type 2B associated with a M918T mutation in RET proto-oncogene. J Korean Soc Endocrinol. 2003; 18(1):85–93.
16. Kim BS, Rhie YJ, Koh H, Kim DH, Choi SH. A case of multiple endocrine neoplasia type 2B early diagnosis by RET proto-oncogene analysis and prophylactic total thyroidectomy. J Korean Soc Pediatr Endocrinol. 2006; 11(1):104–9.
17. Lee MJ, Chung KH, Park JS, Chung H, Jang HC, Kim JW. Multiple endocrine neoplasia type 2b: early diagnosis by multiple mucosal neuroma and its DNA analysis. Ann Dermatol. 2010; 22(4):452–5.
Article
18. Han KJ, Ha MS. Multiple endocrine neoplasia type 2B: early diagnosis based on conjunctival neuroma J Korean Ophthalmol Soc. 2015; 56(2):270–4.
19. Loos F. Veber Doppelseitige Neurofibromatosis der Lider, Konjunktiva und Kornea, der Lipen und der Zunge. Klin Mbl Augenheik. 1932; 89:184–9.
20. Aine E, Aine L, Huupponen T, Salmi J, Miettinen P. Visible corneal nerve fibers and neuromas of the conjunctiva–a syndrome of type-3 multiple endocrine adenomatosis in two generations. Graefes Arch Clin Exp Ophthalmol. 1987; 225(3):213–6.